Internal Medicine, Endocrinology, Diabetes, & Metabolism · Miami, FL
NPI
1710257225
Since 2012
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
11501 SW 40th St
Miami, FL, 33165
Phone (305) 642-5366
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.1M
6,326 prescriptions
Company payments, 2025
$244
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Daile Grave de Peralta prescribed most often to Medicare patients was Levothyroxine Sodium, with 502 prescriptions and refills. In total Daile Grave de Peralta wrote 6,326 Medicare prescriptions that cost $1.1M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-12.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Levothyroxine Sodium Generic | 502 | 1,087 | 159 | $1,196 |
| Metformin Hcl Generic | 337 | 748 | 141 | $1,048 |
| Methimazole Generic | 321 | 480 | 71 | $422 |
| Insulin Degludec Pen (U-200) Insulin Degludec | 316 | 352 | 67 | $63K |
| Trijardy Xr Empaglifloz/Linaglip/Metformin | 275 | 357 | 82 | $121K |
| Metformin Hcl Er Metformin Hcl | 272 | 597 | 111 | $698 |
| Glipizide Er Glipizide | 252 | 530 | 99 | $1,341 |
| Dapagliflozin Dapagliflozin Propanediol | 249 | 288 | 86 | $97K |
| Testosterone Generic | 216 | 225 | 44 | $11K |
| Insulin Glargine-Yfgn Generic | 200 | 212 | 81 | $8,502 |
| Dapagliflozin-Metformin Er Dapaglifloz Propaned/Metformin | 197 | 250 | 52 | $86K |
| Testosterone Cypionate Generic | 193 | 199 | 25 | $4,944 |
| Ozempic Semaglutide | 177 | 192 | 37 | $185K |
| Insulin Degludec Pen (U-100) Insulin Degludec | 177 | 188 | 65 | $13K |
| Trulicity Dulaglutide | 176 | 178 | 29 | $138K |
Brand drugs: 3,316 claims; generic drugs: 2,837 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daile Grave de Peralta $244 ($244 in general payments such as food, travel and fees) from 1 company. The largest payer was Novo Nordisk Inc with $244.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 2 | $244 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.